CryoArcana Releases Our PfCRT Case Study: From 3.3 Å to 2.9 Å Using the Same Data
We are pleased to announce CryoArcana's first case study to show what our cryoEM pipelines can achieve. We revisit PfCRT, the transporter whose mutations help malaria parasites resist chloroquine and piperaquine. At 49 kDa, PfCRT is a small membrane protein in the same size class as many of the GPCRs and transporters in drug discovery pipelines.
Using the Topaz best practices taught in our Topaz Masterclass, we re-picked particles of the PfCRT–Fab complex from the public dataset behind the published structure (Kim et al., Nature 2019; EMPIAR-10330). This resulted in 5× more particles in the final map, and several additional notable improvements, with no new microscope time.
More case studies are on the way, and all of them will be listed at cryoarcana.com/case-studies.
Explore the PfCRT case study at cryoarcana.com/case-studies/pfcrt-topaz-reprocessing. To discuss what better particle picking could do for your own target, request a free feasibility audit at cryoarcana.com/about or contact us at @stcejorpmoc.anacraoyrc or @ssalcretsamzapotmoc.anacraoyrc.
